Cocculus Compositum by Heel USA is used to relieve tinnitus, motion sickness, and nausea. Cocculus Compositum is the same formula as Vertigoheel by Heel. Use Cocculus Compositum during symptoms of tinnitus, motion sickness and nausea. Relief may happen quickly! Available in 100 count tablets and 50mL oral drops.
0
Cocculus Compositum by Heel USA is used to relieve tinnitus, motion sickness, and nausea. Cocculus Compositum is the same formula as Vertigoheel by Heel. Use Cocculus Compositum during symptoms of tinnitus, motion sickness and nausea. Relief may happen quickly! Available in 100 count tablets and 50mL oral drops.
0
  • Heel USA Cocculus Compositum
  • Heel USA Cocculus Compositum

Heel USA Cocculus Compositum

Cocculus Compositum by Heel USA is used to relieve tinnitus, motion sickness, and nausea. Cocculus Compositum is the same formula as Vertigoheel by Heel. Use Cocculus Compositum during symptoms of tinnitus, motion sickness and nausea. Relief may happen quickly! Available in 100 count tablets and 50mL oral drops.

We're sorry, this product has been discontinued.

The related products below might help you find a similar product. Otherwise, please use our search feature to continue your search.

*To the contiguous 48 states.

  • Description
  • Watch Video
  • Label
  • Specifications
  • Reviews

Heel USA Cocculus Compositum

Cocculus Compositum by Heel is a proven, researched homeopathic remedy for tinnitus and vertigo. 

Homeopathic physicians commonly recommend the homeopathic formula, Cocculus Compositum (also known as Vertigoheel), to be used for symptoms which relate to Meniere's Disease:

  • • The temporary relief of motion sickness,
  • • Lightheadedness and nausea, with or without tinnitus or vertigo.

Cocculus Compositum is the only homeopathic all natural formula to be considered as effective as traditional medications for the treatment of vertigo (Meniere's Disease) by an study in the Journal of the American Medical Association (JAMA).

The following is a detailed explanation of the study on Cocculus Compositum (Vertigoheel) in the the JAMA Archives of Otolaryngology - Head and Neck Surgery

ALBUQUERQUE, N.M., August 13, 1998 — A study published in the August issue of the Journal of American Medical Association Archives of Otolaryngology - Head and Neck Surgery shows that VERTIGOHEEL [also known as Cocculus Compositum], a prescription homeopathic medication, is as effective and safe as betahistine, a histamine analogue considered standard therapy in Europe for the management of vertigo symptoms. The publication of this study in JAMA reflects the growing interest in homeopathic medicine. In fact, in the July 15, 1998 issue of the Journal of the American Medical Association (JAMA), a survey of readers identified "alternative medicine" such as homeopathy, as one of the top ten topics of which more information should be published.

Vestibular or balance disorders such as vertigo, dizziness, and motion sickness affect approximately two million people in the U.S. Despite the severity of vertigo, American physicians lack a conventional medication proven to be an effective treatment for the disease. This study represents the first equivalence trial comparing a homeopathic treatment for vertigo to standard drug therapy.

"This is the first time that the AMA has published a study of a homeopathic drug - a study that was designed according to modern scientific methodology," said Dana Ullman, MPH, president of the Foundation for Homeopathic Education and Research and author of numerous books on homeopathy. "Other respected, peer-reviewed medical publications such as The Lancet, Pediatrics and British Medical Journal are now joined by the AMA’s Archives of Otolaryngology in their scientific review of homeopathic studies."

The year-long, double-blind, randomized, controlled clinical trial compared the efficacy and safety of VERTIGOHEEL [ also known as Cocculus Compositum ] with betahistine. The study included 119 male and female patients with acute or chronic vertigo symptoms of various origins. The clinical trial was conducted from 1995 to 1996 at 15 medical clinics throughout Germany. In accordance with good clinical practices, patients were assigned to one of two treatment groups: the VERTIGOHEEL group or the betahistine group. Patients in both groups were given 15 drops three times per day of the active drug (VERTIGOHEEL or betahistine) for 42 consecutive days.

Study Results:

The primary efficacy variables for the study were the frequency, duration, and intensity of vertigo attacks. After six weeks, vertigo-specific complaints were significantly reduced in both treatment groups. VERTIGOHEEL and betahistine were therapeutically equivalent in reducing the duration and intensity of vertigo attacks. Although not clinically significant, VERTIGOHEEL [ Cocculus Compositum ] was marginally superior to betahistine in reducing the frequency of vertigo attacks.

The study's secondary efficacy variables involved quality of life measurements, including physical health and mental activity, from the patients' point of view. These were assessed using the standardized

MOS-SF36 validated quality of life questionnaire as well as a four-part vertigo-specific questionnaire. The patients' and investigators' global assessment of efficacy also comprised the study’s secondary efficacy variables. There was an increase in the patients' quality of life and a significant decrease in vertigo-specific symptoms in both treatment groups. According to investigators, more than 70 percent of patients in both of the VERTIGOHEEL and betahistine groups reported a significant improvement in quality of life. In addition, for more than 90 percent of study patients in both treatment groups, the tolerability of both drugs was rated as "good" or "excellent."

Clinical laboratory data and vital signs for each patient remained essentially unchanged throughout the course of the study, indicating a favorable safety profile for both VERTIGOHEEL and betahistine.

"These results establish VERTIGOHEEL as a safe and effective treatment for vertigo," said study investigator Michael Weiser, PhD, Director of Clinical Research, Heel, GmbH. "VERTIGOHEEL was shown to be as effective as betahistine, a standard anti-vertigo drug, in significantly reducing the frequency and severity of vertigo attacks and was also very well-tolerated. Because of the lack of effective conventional treatments, VERTIGOHEEL fills a serious void for treating millions of Americans suffering from vertigo and other types of dizziness."

"We are excited about the publication of this head-to-head clinical comparison in an American Medical Association (AMA) journal," said Perry Pedersen, Vice President, General Manager, Heel Inc., the U.S. manufacturer and exclusive distributor of VERTIGOHEEL . "Not only does it prove that VERTIGOHEEL is an effective and safe drug for treating vertigo, but it also demonstrates why homeopathic drugs are gaining acceptance among patients and medical practitioners throughout the world. The fact that such a study has been published in an AMA journal is a landmark in itself. The clinical utility of homeopathic drugs like VERTIGOHEEL is now being objectively assessed by our most respected medical institutions."

About Vertigo

Vertigo is a condition where sufferers experience a false sensation of motion - either horizontally or vertically. It is a disorder of the body’s vestibular system, which is located in the inner ear and responsible for maintaining equilibrium. Although many of the causes of vertigo are unknown, the most common causes include head trauma or whiplash, migraine, advanced age, ear infections, viruses, high doses or long-term use of certain antibiotics, stress and fatigue, and stroke or conditions resulting in reduced blood flow to the inner ear or brain. Vestibular disorders, which also include motion sicknesses (e.g., car sickness and sea sickness), are among the most common reasons for doctor visits, with U.S. physicians reporting more than five million related visits per year.

Cocculus Compositum is available in 100 count tablets and 50 mL oral drops. 

Heel USA Cocculus Compositum

Product Certifications:
Manufacturer: Discontinued

Item number: HEE011p

GTIN: 787647100781


Serving Size: 1 Tablet

Serving Per Package: 100

Suggested Use: For adults and children above 6 years, take 1 tablet under the tongue or dissolved completely in mouth 3 times daily or as directed by a physician. For infants and children up to 6 years, 1/2 the adult dosage.

Does Not Contain:
Casein
Corn
Egg
Fish
Gluten
Peanuts
Shellfish
Soy
Tree Nuts
Wheat
Supplement Facts:
Cocculus indicus4X 210 mg-
Conium maculatum3X 30 mg-
Ambra grisea6X 30 mg-
Petroleum8X 30 mg-
 * = Daily Value Based on a standard 2,000 calorie daily intake
** = Daily Value Not Established

Warnings: If symptoms persist or worsen, a physician should be consulted. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before using this product. Store tightly closed at room temperature. Protect from light and moisture. Keep this and all medicines out of the reach of children .

Refrigeration Required: No

Ingredients: Cocculus indicus, Conium maculatum, Ambra grisea, Petroleum.

More

Share your Experience With Others!

Rating 1 star 2 stars 3 stars 4 stars 5 stars